Researchers from KU Leuven, UZ Leuven and the Flemish Institute for Biotechnology (VIB) have found a new way to stop the growth of a rare but very aggressive type of lymphoma. KU Leuven announced this in a press release on Tuesday. By using medication, they can limit the cooperation between two genes, which is at the basis of the development of the cancer.
ttn-3